pazopanib

Generic: pazopanib

Labeler: apotex corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pazopanib
Generic Name pazopanib
Labeler apotex corp.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pazopanib 200 mg/1

Manufacturer
Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-4779
Product ID 60505-4779_13431d63-13a5-2a76-c6de-06799bc59e29
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA217713
Listing Expiration 2026-12-31
Marketing Start 2023-10-19

Pharmacologic Class

Established (EPC)
kinase inhibitor [epc]
Mechanism of Action
protein kinase inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 2c8 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605054779
Hyphenated Format 60505-4779

Supplemental Identifiers

RxCUI
867502
UPC
0360505477975 0360505477951
UNII
7RN5DR86CK
NUI
N0000175605 N0000175076 N0000182141 N0000182137 N0000187062

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pazopanib (source: ndc)
Generic Name pazopanib (source: ndc)
Application Number ANDA217713 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 500 TABLET in 1 BOTTLE (60505-4779-5)
  • 120 TABLET in 1 BOTTLE (60505-4779-7)
source: ndc

Packages (2)

60505-4779-5 500 TABLET in 1 BOTTLE (60505-4779-5) 60505-4779-7 120 TABLET in 1 BOTTLE (60505-4779-7)

Ingredients (1)

pazopanib (200 mg/1)

Linked Drug Pages (1)

Pazopanib ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "13431d63-13a5-2a76-c6de-06799bc59e29", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000187062"], "upc": ["0360505477975", "0360505477951"], "unii": ["7RN5DR86CK"], "rxcui": ["867502"], "spl_set_id": ["b05ea49a-a764-5ff2-6e4a-26add69da9e2"], "pharm_class_epc": ["Kinase Inhibitor [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (60505-4779-5)", "package_ndc": "60505-4779-5", "marketing_start_date": "20231019"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (60505-4779-7)", "package_ndc": "60505-4779-7", "marketing_start_date": "20231019"}], "brand_name": "Pazopanib", "product_id": "60505-4779_13431d63-13a5-2a76-c6de-06799bc59e29", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "60505-4779", "generic_name": "Pazopanib", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pazopanib", "active_ingredients": [{"name": "PAZOPANIB", "strength": "200 mg/1"}], "application_number": "ANDA217713", "marketing_category": "ANDA", "marketing_start_date": "20231019", "listing_expiration_date": "20261231"}